Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
Sponsor: Eli Lilly and Company
A PHASE4 clinical study on Schizophrenia, this trial is completed. The trial is conducted by Eli Lilly and Company and has accumulated 6 data snapshots since 2001. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Aug 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eli Lilly and Company
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aparecida de Goiânia, Brazil, Atlanta, United States, Austin, United States, Barcelona, Spain, Buenos Aires, Argentina, Camberwell, United Kingdom, Caracas, Venezuela, Chicago, United States, Cidra, Puerto Rico, Cincinnati, United States and 50 more location s